Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Prion Deposition in Olfactory Biopsy of Sporadic Creutzfeldt-Jakob Disease
Ann Neurol 55:294-296, Tabaton,M.,et al, 2004
Balint Syndrome Due to Creutzfeldt-Jakob Disease
Neurol 63:395, Ances,B.M.,et al, 2004
Diffusion-Weighted MRI Abnormalities as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease
Neurol 63:443-449,410, Shiga,Y.,et al, 2004
Sensitivity of 14-3-3 Protein Test Varies in Subtypes of Sporadic Creutzfeldt-Jakob Disease
Neurol 63:436-442,410, Castellani,R.J.,et al, 2004
Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004
Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004
Diagnosing Variant Creutzfeldt-Jakob Disease with the Pulvinar Sign:"MR Imaging Findings in 86 Neuropathologically Confirmed Cases
AJNR 24:1560-1569, Collie,D.A.,et al, 2003
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003
Detection of Pathologic Prion Protein in the Olfactory Epithelium in Sporadic Creutzfeldt-Jakob Disease
NEJM 348:711-719,681, Zanusso,G.,et al, 2003
Tau Protein and 14-3-3 Protein in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Neurol 58:192-197, Otto,M.,et al, 2002
Conspicuity and Evolution of Lesions in Creutzfeldt-Jakob Disease at Diffusion-Weighted Imaging
AJNR 23:1164-1172,1070, Murata,T.,et al, 2002
New Variant Creutzfeldt-Jakob Disease Presenting with Loss of Taste and Smell
JNNP 71:412-413, Reuber,M.&Al-Din,A.S.N., 2001
Quantitation of 14-3-3 and Neurol-Specific Enolase Proteins in CSF in Creutzfeldt-Jakob Disease
Neurol 57:728-730, Aksamit,A.L.,et al, 2001
Neurodegenerative Diseases and Prions
NEJM 344:1516-1526,1548, Prusiner,S.B., 2001
Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease
BMJ 322:841-844, Brown,P., 2001
CSF Detection of the 14-3-3 Protein in Unselected Patients with Dementia
Neurol 56:1528-1533, Burkhard,P.R.,et al, 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Current Clinical Diagnosis in Creutzfeldt-Jakob Disease; Identification of Uncommon Variants
Ann Neurol 48:323-329, Zerr,I. et al, 2000
14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease
Neurol 55:514-516, Lemstra,A.W. et al, 2000
Analysis of EEG and CSF 14-3-3 proteins as adis to the diagnosis of Creutzfeldt-Jakob Disease
Neurol 55:811-815, Zerr,I. et al, 2000
Variant Creutzfeldt-Jakob Disease in UK children: A National Surveillance Study
Lancet 356: 1224-1227, Verity,C.M.,et al, 2000
Dementia with Lewy Bodies in a Neuropathologic Series of Suspected Creutzfeldt-Jakob Disease
Neurol 55:1401-1404, Haik,S.,et al, 2000
The Pulvinar Sign on Magnetic Resonance Imaging in Variant Creutzfeldt-Jakob Disease
Lancet 355:1412-1418,1384, Zeidler,M.,et al, 2000
Diagnosis of New Variant Creutzfeldt-Jakob Disease
Ann Neurol 47:575-582, Will,R.G.,et al, 2000
Risk of Transmission of Bovine Spongiform Encephalopathy to Humans in the United States, Report of the Council on Scientific Affairs
JAMA 281:2330-2339, Tan,L.,et al, 1999
Variant Creutzfeldt-Jakob Disease
Lancet 354:317-323, Collinge,J., 1999
Abnormal Diffusion-Weighted Magnetic Resonance Images in Creutzfeldt-Jakob Disease
Arch Neurol 56:577-583, Bahn,M.M.,&Parchi,P., 1999
Mortality from Dementia in Occupations at Risk of Exposure to Bovine Spongiform EncephalopathyAnalysis of Death Registrations
BMJ 318:1044-1045, Aylin,P.,et al, 1999
Diffusion-Weighted MRI in Sporadic Creutzfeldt-Jakob Disease
Neurol 52:205-208, Demaerel,P.,et al, 1999
Investigation of Variant Creutzfeldt-Jakob Disease and Other Human Prion Diseases with Tonsil Biopsy Samples
Lancet 353:183-189,163, Hill,A.F.,et al, 1999
The Heidenhain Variant of Creutzfeldt-Jakob Disease
Arch Neurol 56:55-61, Kropp,S.,et al, 1999
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
An Unusual Case of Creutzfeldt-Jakob Disease
Neurol 51:617-619, Vingerhoets,F.J.G.,et al, 1998
Detection of 14-3-3 Protein in Cerebrospinal Fluid Supports Dx of Creutzfeldt-Jakob Disease
Ann Neurol 43:32-40, Zerr,I.,et al, 1998
Diagnosis of Creutzfeldt-Jakob Disease by Measurement of S100 Protein in Serum:Case-Control Study
BMJ 316:577-581, 5631998., Otto,M.,et al, 1998
SPECT in the Identif of New Variant Creutzfeldt-Jakob Disease:Case Reports
BMJ 316:593-594, 5631998., deSilva,R.,et al, 1998
The Role of 99m-Tc HMPAO SPECT in the Diagnosis of Creutzfeldt-Jacob Disease
AJNR 19:454-455, Miller,D.A.,et al, 1998
Transmissible Spongiform Encephalopathies
NEJM 337:1821-1828, Haywood,A.M., 1997
Diffusion-Weighted Magnetic Resonance Imaging in Creutzfeldt-Jakob Disease
Lancet 349:847-848, Demarerel,P.,et al, 1997
The 14-3-3 Brain Protein and Transmissible Spongiform Encephalopathy
NEJM 336:873-875, Moussavian,M.,et al, 1997
Rapid Spongiform Degeneration of the Cerebrum and Cerebellum in Creutzfeldt-Jakob Encephalitis:Serial MR Findings
AJNR 18:583-586, Tzeng,B-C.,et al, 1997
The Risk of Bovine Spongiform Encephalopathy ('Mad Cow Disease') to Human Health
JAMA 278:1008-1011, Brown,P., 1997
Detection of 14-3-3 Protein in the CSF of Genetic Creutzfeldt-Jakob Disease
Neurol 49:593-595, Rosemann,H.,et al, 1997
New Variant Creutzfeldt-Jakob Disease:Neurological Features and Diagnostic Tests
Lancet 350:903-907, Zeidler,M.,et al, 1997
New Variant Creutzfeldt-Jakob Disease:Psychiatric Features
Lancet 350:908-910, Zeidler,M.,et al, 1997
Bovine Spongiform Encephalopathy and a New Variant of Creutzfeldt-Jakob Disease
Neurol 48:569-571, Epstein,L.G.&Brown,P., 1997
Diagnosis of New Variant Creutzfeldt-Jakob Disease by Tonsil Biopsy
Lancet 349:99-100, Hill,A.F.,et al, 1997
Brain magnetic Resonance Diffusion Abnormalities in Creutzfeldt-Jakob Disease
Arch Neurol 54:1411-1415, Bahn,M.M.,et al, 1997
The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies
NEJM 335:924-930, 9631996., Hsich,G.,et al, 1996